Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
1.460
-0.080 (-5.19%)
Dec 5, 2025, 4:00 PM EST - Market closed
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $120.30 million as of December 5, 2025. Its market cap has increased by 65.16% in one year.
Market Cap
120.30M
Enterprise Value
83.20M
1-Year Change
65.16%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $120.30M, a decrease of -85.09%. That is a compound annual growth rate of -30.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 120.30M | 24.37% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | 3.03B | 276.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 930.92B |
| Johnson & Johnson | 494.65B |
| AbbVie | 406.09B |
| UnitedHealth Group | 306.76B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 254.80B |
| Thermo Fisher Scientific | 220.29B |